Results 261 to 270 of about 62,619,193 (270)

CDK4/6 Inhibitors: The Mechanism of Action May Not Be as Simple as Once Thought

Cancer Cell, 2018
William D Tap, Marta Kovatcheva, Lara E Davis   +2 more
exaly  

Recent Developments of Transition-State Analogue Glycosidase Inhibitors of Non-Natural Product Origin

Chemical Reviews, 2002
Mikael Bols, Xifu Liang, Mikael Bols*
exaly  

Neuer IL-23-Inhibitor: höhere Wirksamkeit als Standardbiologika

hautnah dermatologie, 2018
openaire   +1 more source

Real-World Evidence on Dose Spacing of IL-23 Inhibitors in the Treatment of Psoriasis

American Journal of Clinical Dermatology
Martim Luz, Tiago Torres
openaire   +2 more sources

Switching within the class of IL‐23 inhibitors for the treatment of psoriasis: A systematic review

Journal of the European Academy of Dermatology and Venereology
Ioannis‐Alexios Koumprentziotis, Irene Stefanaki, Alexander Stratigos, Electra Nicolaidou   +3 more
openaire   +2 more sources

CYCLIC PEPTIDE INHIBITORS OF IL-23

GUO BOYING, HENDRICK CHARLES, MARCOUX DAVID, NEELAMKAVIL SANTHOSH, PATCH RAYMOND J, SOMANI SANDEEP, SUN CHENGZAO, THIEU THO VAN, ZHANG JING, BARROS STEPHANIE, BRANCA DANILA, BIANCHI ELISABETTA, COSTANTE ROBERTO, INGENITO RAFFAELE, CAVALLO GIANNI   +14 more
openaire   +1 more source

NEW PEPTIDES AS SELECTIVE IL-23 RECEPTOR INHIBITORS

BOEHME THOMAS, HAACK TORSTEN, KURZ MICHAEL, LI ZIYU, POEVERLEIN CHRISTOPH, TIWARI GARIMA   +5 more
openaire   +3 more sources

Neuer IL-23-Inhibitor bei aktivem Morbus Crohn

Gastro-News
openaire   +1 more source

IL-23 inhibitors go head to head in Crohn’s disease

Nature Medicine
openaire   +1 more source

Recent Advances in Crohn's Disease Therapy: IL-23 Inhibitors vs JAK Inhibitors

Ziad Tamer, Mahmoud Magdy Abu Sarea
openaire   +1 more source